Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

HK Type 4 license through Ballingal Investment Advisors Ltd. ("BIA" or "BIAL")

BACKGROUND
I have 20+yrs experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies with most of that time spent managing money. 

4 years in fixed income macro, 8 years running internal hedge fund and 4yrs investment banking at Citi in Japan, 3 years running an Asia multi-strat portfolio at a hedge fund, 4+yrs as an independent special situations analyst.

Pan-Asia Catalysts/Events

JAFCO (8595) Yields to Murakami Greenmail - Big Asset Sale, Big Buyback

Nomura Research Institute (4307) Large Secondary Offering - Demand Profile and Index Implications

NRI (4307) Likely Prices Today - Expect Weakness Then Strength

JAFCO (8595) Vs Murakami - It's On, So We Wait

Quiddity Advisors

Event-Driven

<ul>
<li>Entities related to noted Japanese activist Yoshiaki Murakami had bought 11+%, suggested 15%, proposed 51%, and pestered <a href="https://www.smartkarma.com/entities/jafco-co-ltd" target="_blank" data-smartkarma-citation="entities:8848:1" rel="noopener">Jafco Co Ltd (8595 JP)</a> for an asset sale and super-large buyback. </li>
<li>JAFCO decided to launch a poison pill process as a hostile takeover defence mechanism, with the Record Date at August month-end.</li>
<li>The shares popped. I was bearish. It turns out Murakami affiliates sold the pop. And this starts the range trade.</li>
</ul>


Entities related to noted Japanese activist Yoshiaki Murakami had bought 11+%, suggested 15%, proposed 51%, and pestered Jafco Co Ltd (8595 JP) for an asset sale and super-large buyback. 
JAFCO decided to launch a poison pill process as a hostile takeover defence mechanism, with the Record Date at August month-end.
The shares popped. I was bearish. It turns out Murakami affiliates sold the pop. And this starts the range trade.


JAFCO (8595) Down as Murakami Affiliates Sell the Pop on the Poison Pill, So Buy the Range Dip